Phibro Animal Health Corp. (PAHC)
35.36
-0.96
(-2.64%)
USD |
NASDAQ |
Aug 24, 16:00
35.36
0.00 (0.00%)
After-Hours: 20:00
Phibro Animal Health Net Income (Quarterly) : 24.02M for March 31, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 24.02M |
| December 31, 2025 | 27.46M |
| September 30, 2025 | 26.53M |
| June 30, 2025 | 17.22M |
| March 31, 2025 | 20.88M |
| December 31, 2024 | 3.185M |
| September 30, 2024 | 6.975M |
| June 30, 2024 | 0.752M |
| March 31, 2024 | 8.405M |
| December 31, 2023 | 1.274M |
| September 30, 2023 | -8.015M |
| June 30, 2023 | 11.50M |
| March 31, 2023 | 10.04M |
| December 31, 2022 | 7.21M |
| September 30, 2022 | 3.856M |
| June 30, 2022 | 7.487M |
| March 31, 2022 | 17.69M |
| December 31, 2021 | 17.46M |
| September 30, 2021 | 6.534M |
| June 30, 2021 | 17.12M |
| March 31, 2021 | 12.16M |
| December 31, 2020 | 12.80M |
| September 30, 2020 | 12.30M |
| June 30, 2020 | 5.60M |
| March 31, 2020 | 13.50M |
| Date | Value |
|---|---|
| December 31, 2019 | 11.89M |
| September 30, 2019 | 2.515M |
| June 30, 2019 | 8.80M |
| March 31, 2019 | 14.85M |
| December 31, 2018 | 14.75M |
| September 30, 2018 | 16.31M |
| June 30, 2018 | 22.10M |
| March 31, 2018 | 19.84M |
| December 31, 2017 | 7.032M |
| September 30, 2017 | 15.89M |
| June 30, 2017 | 15.40M |
| March 31, 2017 | 23.64M |
| December 31, 2016 | 13.42M |
| September 30, 2016 | 12.18M |
| June 30, 2016 | 15.20M |
| March 31, 2016 | 18.58M |
| December 31, 2015 | 30.18M |
| September 30, 2015 | 18.75M |
| June 30, 2015 | 10.40M |
| March 31, 2015 | 16.70M |
| December 31, 2014 | 15.40M |
| September 30, 2014 | 20.48M |
| June 30, 2014 | -17.64M |
| March 31, 2014 | 6.37M |
| December 31, 2013 | 2.302M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Zoetis, Inc. | 691.00M |
| Merck & Co., Inc. | -1.337B |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 383.54M |
| Total Expenses (Quarterly) | 359.52M |
| EPS Diluted (Quarterly) | 0.5854 |
| Enterprise Value | 2.183B |
| Gross Profit Margin (Quarterly) | 32.56% |
| Profit Margin (Quarterly) | 6.26% |
| Earnings Yield | 6.58% |
| Operating Earnings Yield | 12.71% |
| Normalized Earnings Yield | 7.103 |